Opticyte
Manufacturing · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4000 Mason Rd S 300, Seattle, Washington...Phone Number
(206) 775-5525Website
www.opticyte.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Opticyte
Opticyte is a healthcare technology company that has developed the VitalO₂, the world's first device capable of measuring oxygen levels inside cells in real-time. Their innovative solution aims to transform the standard of care for sepsis and other causes of organ failure, addressing significant healthcare disparities, particularly for people of color. The device is designed for use in emergency departments, intensive care units, and operating rooms, providing critical data to healthcare providers. Opticyte is committed to improving early detection and treatment of life-threatening conditions, ultimately saving lives and promoting health equity.Explore more
Opticyte Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Opticyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Opticyte
Check out if Opticyte is spiking on competitors!
Opticyte, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Opticyte has new funding data
Check if Opticyte has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Opticyte recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Opticyte had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Opticyte launches new products
Recommended Actions
Reach out to Masked Content who joined Opticyte as Masked Content
Find more new buyers
Compare Similar Companies to Opticyte
Compare insights from companies similar to Opticyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Opticyte is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Opticyte is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Opticyte.
Opticyte financials insights
Gather financial insights about Opticyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Grant
$2.9M
Angel/Seed
$1.7M
Opticyte Tech Stack
A closer look at the technologies used by Opticyte
Most Recent Scoops
Project
Product Management
Funding
Funding
Funding
Opticyte News & Media
Opticyte Earns FDA Breakthrough Device Designation for the First Cell O2 Patient Monitor for Organ Failure
SEATTLE--(BUSINESS WIRE)--Opticyte's Cell O₂ Patient Monitor received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).Opticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure
SEATTLE--(BUSINESS WIRE)--Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low oxygen levels in cells to prevent organ failure, announced the recent culmination of private capital and grant funding. The $4.6MM in funding is enabling Opticyte to address sepsis–the primary cause of organ failure and the most expensive condition to treat for in the U.S. healthcare system. Opticyte’s real-time tecUW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure
University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The Seattle startup is developing a non-invasive technology that can detect oxygen levels in cells in real time. The Opticyte Cell O2 Monitor could help in the treatment of sepsis, which is an infection that runs amuck and can cause organs to shut down, resulting in death. If a sepsis patient sees their cellular oxygen levels
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Opticyte
Sign Up For FreeTo access detailed company insights
Opticyte is a healthcare technology company that has developed the VitalO₂, the world's first device capable of measuring oxygen levels inside cells in real-time. Their innovative solution aims to transform the standard of care for sepsis and other causes of organ failure, addressing significant healthcare disparities, particularly for people of co... Read More
